N/A
N=12
Increasing Activity in Liver Transplant Patients
Liver Transplant
Bottom Line
View on ClinicalTrials.gov: NCT02058498 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jun 2016
Primary outcome: Primary: Physical Activity Measured by the International Physical Activity Questionnaire (IPAQ) — 407; 1711 MET
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Physical activity (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Physical Activity Measured by the International Physical Activity Questionnaire (IPAQ) |
407; 1711 | — |
| SECONDARY Quality of Life at Baseline, 6 Weeks, and 4 Months |
5.5; 8.25; 8.3 | 0.27 |
| SECONDARY Number of Patients Who Document Their Physical Activity |
8; 6 | — |
Summary
Will adult liver transplant patients who are provided with physical activity (walking) instructions increase their physical activity and perceive an improved quality of life?
Eligibility Criteria
Inclusion criteria
- Adult patients 18-65 years of age who receive a liver transplant at Mayo Clinic Jacksonville.
- Adult patients who are 5-21 days post liver transplant.
- Must be followed by Mayo Clinic Jacksonville at 4 months postoperatively.
- Approved by a hepatologist and/or transplant surgeon to participate.
Exclusion criteria
- Patients with active infections
- Patients with encephalopathy or cognitive dysfunction
- Patients who receive a combined liver-kidney transplant
- Patients with severe debility
- Patients who require assistance to ambulate.
Data sourced from ClinicalTrials.gov (NCT02058498). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.